CD8

[Scientific Reports] Intravenously treating with single strain for three times, or with both strains alternately for three times significantly reduced the tumor size and prolonged the survival time of model mice.

[Scientific Reports] Scientists established liver tumor cell lines from hepatitis C virus transgenic mice fed an atherogenic high-fat diet.

[Bone Marrow Transplantation] Mice were followed for xenogeneic graft-versus-host disease score and survival. Human T-cell engraftment and as well as human T-cell subtypes were monitored in blood on days 14, 21, and 28 after transplantation.

[Nature Communications] Using a transplantable mouse model of prostate carcinoma, scientists reported that tumor challenge leads to expansion of naïve neoantigen-specific CD8+ T cells and formation of a small population of non-recirculating tissue-resident memory T cells in several non-lymphoid tissues.

[Cell Reports] Delivery of regulatory macrophages (Mregs) completely abolished the priming of cognate CD8 cells and strongly reduced delayed-type hypersensitivity reactions. Mreg-mediated T cell suppression requires cell-cell contact-regulated nitric oxide production.

[Nature Biomedical Engineering] The authors showed in multiple murine tumor models that inulin-a widely consumed dietary fiber-formulated as a ‘colon-retentive’ orally administered gel could effectively modulate the gut microbiome in situ, induced systemic memory-T-cell responses and amplified the antitumour activity of the checkpoint inhibitor anti-programmed cell death protein-1.